Incyte Corp (INCY)
52.81
+0.10
(+0.19%)
USD |
NASDAQ |
Apr 18, 16:00
52.81
0.00 (0.00%)
After-Hours: 20:00
Incyte Cash from Operations (TTM): 496.49M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 496.49M |
| September 30, 2023 | 632.42M |
| June 30, 2023 | 780.97M |
| March 31, 2023 | 648.60M |
| December 31, 2022 | 969.94M |
| September 30, 2022 | 801.63M |
| June 30, 2022 | 760.35M |
| March 31, 2022 | 759.13M |
| December 31, 2021 | 749.49M |
| September 30, 2021 | 741.46M |
| June 30, 2021 | 668.48M |
| March 31, 2021 | 764.91M |
| December 31, 2020 | -124.60M |
| September 30, 2020 | -100.30M |
| June 30, 2020 | -12.00M |
| March 31, 2020 | -128.42M |
| December 31, 2019 | 710.66M |
| September 30, 2019 | 662.88M |
| June 30, 2019 | 591.61M |
| March 31, 2019 | 471.05M |
| December 31, 2018 | 336.23M |
| September 30, 2018 | 163.12M |
| June 30, 2018 | 17.10M |
| March 31, 2018 | 101.49M |
| December 31, 2017 | -92.99M |
| Date | Value |
|---|---|
| September 30, 2017 | 90.66M |
| June 30, 2017 | 132.80M |
| March 31, 2017 | 33.58M |
| December 31, 2016 | 304.76M |
| September 30, 2016 | 283.26M |
| June 30, 2016 | 195.71M |
| March 31, 2016 | 191.53M |
| December 31, 2015 | 89.41M |
| September 30, 2015 | 61.25M |
| June 30, 2015 | 81.31M |
| March 31, 2015 | 53.36M |
| December 31, 2014 | 26.26M |
| September 30, 2014 | -30.15M |
| June 30, 2014 | -69.89M |
| March 31, 2014 | -47.25M |
| December 31, 2013 | 9.18M |
| September 30, 2013 | -1.139M |
| June 30, 2013 | -16.33M |
| March 31, 2013 | -15.69M |
| December 31, 2012 | -94.83M |
| September 30, 2012 | -112.60M |
| June 30, 2012 | -132.43M |
| March 31, 2012 | -171.89M |
| December 31, 2011 | -161.72M |
| September 30, 2011 | -94.53M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-128.42M
Minimum
Mar 2020
969.94M
Maximum
Dec 2022
545.98M
Average
668.48M
Median
Jun 2021
Cash from Operations (TTM) Benchmarks
| Novartis AG | 14.46B |
| MorphoSys AG | -- |
| Illumina Inc | 478.00M |
| Biogen Inc | 1.547B |
| Exelixis Inc | 333.32M |